Imatinib Mesylate exporters, bulk pharmaceutical,Imatinib Mesylate Cas No. 220127-57-1,Suppliers, distributors, producers, product, traders, dealers, features, details, uses,

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Imatinib-Mesylate Taj API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Imatinib Mesylate Manufacturers in India Suppliers Imatinib Mesylate Dossage Exporters Distributors Imatinib Mesylate api active pharmaceuticals ingredients Imatinib Mesylate manufacturers Side Effects bulk drugs raw material Dossage Imatinib Mesylate companies Side Effects Dossage Importers Imatinib Mesylate Dossage Imatinib Mesylate Exporters Imatinib Mesylate exporters Dossage FDA Dossage Imatinib Mesylate Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Imatinib Mesylate manufacturing pharmaceutical drugs pharmaceutical intermediates Imatinib Mesylate pharmaceutical chemicals pharmaceutical raw materials Imatinib Mesylate active pharmaceutical ingredients Imatinib Mesylate committee active pharmaceutical ingredients manufacturer Imatinib Mesylate Active Pharmaceutical Ingredients manufacturer Imatinib Mesylate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Imatinib Mesylate, Imatinib Mesylate manufacturer India, Imatinib Mesylate product, Imatinib Mesylate products, Api preparation, Certificate of Analysis API manufacturer product, Imatinib Mesylate anti ulcer product, Certificate of Origin COA Imatinib Mesylate COS Imatinib Mesylate, pharmaceutical generic, pharmaceutical drug, medical, Imatinib Mesylate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Imatinib Mesylate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Imatinib Mesylate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Imatinib Mesylate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Imatinib Mesylate ingredients, api, HIV Imatinib Mesylate, tablets, capsules, syrup & protein Imatinib Mesylate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Imatinib Mesylate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Imatinib Mesylate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

pharma Imatinib Mesylate

HOME >> API >> API List 2 >> Imatinib Mesylate >> Dosage

DOSAGE
Imatinib Mesylate

Imatinib mesylate is a pill, taken by mouth, once or twice daily.
Imatinib mesylate should be taken with a large glass of water, after a meal.
The amount of Imatinib mesylate that you will receive depends on many factors, including your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.Pediatric patients with Ph+ CML in chronic phase who are newly diagnosed or whose disease has recurred after stem cell transplant or who are resistant to interferon-alpha therapy. There are no controlled trials in pediatric patients demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival.Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemiaAdult patients with myelodysplastic/ myeloproliferative diseases associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangementsAdult patients with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE >>

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin	Gemcitabine Hcl	Glimepiride	Granisetron Hcl	Ibandronate Sodium	Imatinib Mesylate	Irbesartan	Irinotecan Hcl	Isradipine	Lamotrigine
Lercanidipine	Letrozole	Losartan Potassium	Loteprednol Etabonate	Magnesium Valproate	Meloxicam	Memantine Hcl	Mesalazine	Metamizol Magnesium	Metaxalone
Metformin Hcl	Metoprolol Tartrate	Mifepristone	Mirtazapine	Modafinil	Mometasone Furoate	Naltrexone Hcl	Netaglinide

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.